Should You Be Worried About the Return of Big Pharma Deals?

Should You Be Worried About the Return of Big Pharma Deals?

Source: 
Motley Fool
snippet: 

Plenty of big pharmaceutical companies started 2018 with piles of cash burning holes in their pockets. The pace of acquisitions and large licensing deals cooled off after hitting a crescendo in late April, but plenty of the industry's well-heeled members are still eager to invest.